Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Malin Boremalm

3PUBLICATIONS
7CO-AUTHORS
Medical virologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 25, 2024
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

Susanna Hallberg, Björn Evertsson, Ellen Lillvall

|Jan 21, 2021
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis.

Malin Boremalm, Peter Sundström, Jonatan Salzer

|Feb 15, 2019
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis.

M Boremalm, A Juto, M Axelsson

Pageof 1

Frequent Collaborators

2 joint publications

Anders Svenningsson

2 joint publications

Jan Lycke

1 joint publications

Susanna Hallberg

1 joint publications

Björn Evertsson

1 joint publications

Jonatan Salzer

1 joint publications

Katharina Fink

1 joint publications

Thomas Frisell

Frequent Collaborators

2 joint publications

Anders Svenningsson

2 joint publications

Jan Lycke

1 joint publications

Susanna Hallberg

1 joint publications

Björn Evertsson

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on : May 09, 2025

506
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on : Jul 19, 2019

12.0K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on : May 09, 2025

506
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on : Jul 19, 2019

12.0K
See more related videos